Sanjeeva Reddy
Impact in
- Organic Chemistry top 10%
- Synthesis and biological activity
- Multicomponent Synthesis of Heterocycles
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
- Quinazolinone synthesis and applications
- Toxicology top 10%
Papers in
-
- Melanoma and MAPK Pathways 10
- Cell death mechanisms and regulation 2
- Oncology 10
- Cytokine Signaling Pathways and Interactions 5
- HER2/EGFR in Cancer Research 3
- Co-authors
- John Herich (2 shared papers)John Drewe (2 shared papers)Shailaja Kasibhatla (2 shared papers)Ben Tseng (2 shared papers)Sui Xiong Cai (2 shared papers)Karen Meerovitch (1 shared paper)Quan Yang (1 shared paper)Henriette Gourdeau (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (7 papers)Cancer Research (6 papers)Journal of Clinical Oncology (4 papers)Journal of Medicinal Chemistry (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Sanjeeva Reddy
26 papers receiving 337 citations
Peers
Comparison fields: 5 of 48
- Organic Chemistry 235
- Toxicology 20
- Pharmacology 75
- Oncology 62
- Cancer Research 28
Countries citing papers authored by Sanjeeva Reddy
This map shows the geographic impact of Sanjeeva Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjeeva Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjeeva Reddy more than expected).
Fields of papers citing papers by Sanjeeva Reddy
This network shows the impact of papers produced by Sanjeeva Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjeeva Reddy. The network helps show where Sanjeeva Reddy may publish in the future.
Co-authors
The 25 scholars most cited alongside Sanjeeva Reddy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 177 | |
| 2 | 2003 | 79 | |
| 3 | Analysis of transcription and protein expression changes in the 786-O human renal cell carcinoma tumor xenograft model in response to treatment with the multi-kinase inhibitor sorafenib (BAY 43-9006) | 2006 | 25 |
| 4 | 2021 | 19 | |
| 5 | 2021 | 19 | |
| 6 | 2008 | 12 | |
| 7 | 2015 | 5 | |
| 8 | 2017 | 5 | |
| 9 | 2015 | 5 | |
| 10 | 2019 | 4 | |
| 11 | 2015 | 3 | |
| 12 | 2015 | 3 | |
| 13 | 2020 | 3 | |
| 14 | 2017 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2018 | 2 | |
| 18 | 2020 | 2 | |
| 19 | 2017 | 1 | |
| 20 | 2018 | 1 |
About Sanjeeva Reddy
Sanjeeva Reddy is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 26 papers that have together received 377 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (10 papers), Synthesis and biological activity (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Cytokine Signaling Pathways and Interactions (5 papers), Computational Drug Discovery Methods (4 papers), HER2/EGFR in Cancer Research (3 papers), Cell death mechanisms and regulation (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Organic Chemistry (235 citations), Toxicology (20 citations), Pharmacology (75 citations), Oncology (62 citations) and Cancer Research (28 citations). Sanjeeva Reddy has collaborated with scholars based in United States and India. Frequent co-authors include John Herich, John Drewe, Shailaja Kasibhatla, Ben Tseng, Sui Xiong Cai, Karen Meerovitch, Quan Yang, Henriette Gourdeau, Serge Lamothe and Ling Qiu. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Journal of Clinical Oncology, Journal of Medicinal Chemistry and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.